Peter Fedichev, PhD
Company: Gero LLC
Job title: Founder and Chief Science
Dr. Fedichev is Founder and Chief Science Officer of Gero, a data-driven longevity company aiming to be first to introduce life-extending therapies to market. Gero R&D team led by Dr. Peter Fedichev presented a physics-based explanation of aging fundamentals now turned into cutting-edge modeling platform for anti-aging targets and aging biomarkers identification.
Dr. Fedichev earned his M.S. in theoretical physics from the Moscow Institute of Physics and Technology and his Ph.D. from the University of Amsterdam. He was top-2 cited Russian physicist under 35 before he switched to biotech 15 years ago, and conducted research at AMOLF, an academic institute for fundamental physics in the Netherlands, as well as at the University of Innsbruck. He continues his studies in the field of aging biology and biophysics serving as Gero Chief Science Officer and a Head of the Laboratory of Biological Systems Simulation at MIPT and currently has more than 70 papers published in peer-reviewed journals.
Hacking Aging: A Data-Driven Approach to Healthy Life Extension 3:00 pm
Discussing physical kinetics of aging for systematic discovery of aging biomarkers and anti-aging targets Exploring the discovery of aging biomarkers in longitudinal blood data and physical records from wearable devices Analyzing time scales involved in aging dynamics: implications for preclinical research and clinical trials Presenting an interim report: plasma proteome as the target for therapeutic…Read more
day: Day One